These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7270558)

  • 1. Escalating costs for cancer chemotherapy.
    Nyman JV; Dorr RT; Hall GR
    Am J Hosp Pharm; 1981 Aug; 38(8):1151-4. PubMed ID: 7270558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient cancer drug costs: changes, drivers, and the future.
    Halbert RJ; Zaher C; Wade S; Malin J; Lawless GD; Dubois RW
    Cancer; 2002 Feb; 94(4):1142-50. PubMed ID: 11920485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The cost of chemotherapy].
    Lévy C; Bonastre J
    Bull Cancer; 2003 Nov; 90(11):976-82. PubMed ID: 14706901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost of medications in the oncology sector in the context of health economics].
    Walter E; Batista A
    Wien Med Wochenschr; 2008; 158(7-8):227-33. PubMed ID: 18500477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
    Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hospital information systems ineffectiveness in costing ambulatory chemotherapy in pulmonary oncology].
    Thomas P; Raholimina V; Ferri-Dessens RM; Pibarot M; Penot Ragon C; Gregoire R; Kleisbauer JP
    Rev Mal Respir; 2000 Jun; 17(3):659-63. PubMed ID: 10951960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [[How to finance chemotherapy with new cancer drugs?].
    Livartowski A; Beuzeboc P; Le Vu B; Courbard M; Pierga JY; Extra JM; Scholl S; Pouillart P
    Bull Cancer; 2000 Oct; 87(10):745-54. PubMed ID: 11084538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.
    Maslove L; Gower N; Spiro S; Rudd R; Stephens R; West P
    Thorax; 2005 Jul; 60(7):564-9. PubMed ID: 15994264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Projecting future drug expenditures--1994.
    Santell JP
    Am J Hosp Pharm; 1994 Jan; 51(2):177-87. PubMed ID: 8160668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Refining the French system of cost assessment for oncology patients following chemotherapy].
    Lévy-Piedbois C; Borella L; Bergerot P; Peuvrel P; Erard C; Parmentier G; Ravaud A; Trombert Paviot B; Armand JP; Rodrigues JM
    Bull Cancer; 2003 Nov; 90(11):989-96. PubMed ID: 14706903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-line and third-line chemotherapy for lung cancer: use and cost.
    Ramsey SD; Martins RG; Blough DK; Tock LS; Lubeck D; Reyes CM
    Am J Manag Care; 2008 May; 14(5):297-306. PubMed ID: 18471034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Projecting future drug expenditures--1993.
    Santell JP
    Am J Hosp Pharm; 1993 Jan; 50(1):71-7. PubMed ID: 8427283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of concurrent chemoradiation in comparison with radiation alone in locally advanced cervical cancer.
    Manusirivithaya S; Sripramote M; Tangjitgamol S; Sanjareonsuttikul N; Pisarnturakit P
    J Med Assoc Thai; 2005 Aug; 88(8):1035-44. PubMed ID: 16404829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of health care services in the treatment of cancer.
    Ilbery PL
    Aust Fam Physician; 1978 Aug; 7(8):1062-74. PubMed ID: 101189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bottom-up analysis of the case costs of stem cell transplantation and selected chemotherapies].
    Stäbler W; Wagner B
    Klin Padiatr; 2003; 215(3):179-84. PubMed ID: 12778360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.